GOLDSTEIN DOV A MD - 18 Feb 2025 Form 4 Insider Report for BioAge Labs, Inc. (BIOA)

Role
Chief Financial Officer
Signature
/s/ Dov A. Goldstein
Issuer symbol
BIOA
Transactions as of
18 Feb 2025
Transactions value $
$0
Form type
4
Filing time
20 Feb 2025, 16:19:02 UTC
Previous filing
03 Jan 2025
Next filing
25 Feb 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIOA Stock Option (Right to Buy) Award $0 +170,000 $0 170,000 18 Feb 2025 Common Stock 170,000 $4.38 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vested or vests as to 1/48th of the total award monthly, with the first tranche vesting on February 1, 2025, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.